,31 The present study raises the possibility of targeted HER2 therapy as an adjuvant alternative for these cases of GTN, given the substantial positivity for this protein in our cases, making it an additional treatment option for patients with more severe disease. This evidence concerns the gene ERBB2 and gestational trophoblastic neoplasm.